Doctors Vaccinate For Profit

January 26, 2010

VacTruth

by Christina England

Years ago children were sent up chimneys or sold as servants to earn their parents extra money. Now they are being vaccinated by doctors, to boost their takings. Doctors, Governments and Pharma see our children as their property and are making thousands of pounds/dollars/euros out of them right under our noses. This, they call ‘Health Care’, I call it the legalization of child labour.

For years now we have been told that vaccines are good for us, that vaccines eradicate illness and that vaccines will save us from killer diseases. What we are not told is that the doctors and Governments telling us this are often linked to the drug companies who are manufacturing the vaccines that they promote and many are making thousands of pounds/dollars profit from vaccinating our children.

Let us begin at the bottom and start with the GP. In the UK every time a vaccine is given to us by our trusted GP they are paid. The British Medical Journal published an article GPs make deals with local NHS to vaccinate children against swine flu explaining how that every single child who is vaccinated with the H1N1 in the UK will earn the GP £5.25.

In Ireland the GP’s are paid five times this amount, for the seasonal flu shot. The article Irish Times – Irish GP’s paid five times UK rate for flu vaccine report that in Ireland a GP will earn a staggering €38.95 per vaccine, making vaccines a very lucrative business indeed.

As far back as 2002, GP’s were so keen to get their hands on this extra money that they were striking off their lists the children who had not had the MMR because if they (the GP’s ) did not meet the Government target rate of 90% immunization, they would not earn their £2865 vaccination bonus Daily Telegraph – Children without MMR jab struck off GP’s list reports tells the full story.

In another article The campaign for Gardasil Flawed it is reported that Merck actually seeks out and trains doctors to lecture for them on Gardasil, paying them $4,500 each time they lecture on the Gardasil vaccine. Doctors are making thousands of dollars doing this.

This is nothing new and is not just attributed to vaccines. Doctors have been doing this for years.

In the article Ex-Drug Sales Rep Tells All – ABC News

one drugs representative spills the beans and tells a Congressional committee what really goes on. Speaking about Eli Lilly he told the committee:-

“To sell their drugs, pharmaceutical companies hire former cheerleaders and ex-models to wine and dine doctors, exaggerate the drug’s benefits and underplay their side-effects”

Shahram Ahari, who spent two years selling Prozac and Zypraxa for Eli Lily, told a Senate Aging Committee chaired by Sen. Herb Kohl, D-Wisc., that his job involved ” rewarding physicians with gifts and attention for their allegiance to your product and company despite what may be ethically appropriate.”

Ahari claimed that drug companies like hiring former cheerleaders and ex-models, as well as former athletes and members of the military, many of whom have no background in science to wine and dine the doctors explaining the wonderful benefits of the drug they are employed to sell.

Higher up the you have leading figures in the medical profession who advise Governments on vaccine policies have strong links and alliances with the drugs companies helping them peddle their wares.

Click here for full report

Former Head of CDC Lands Lucrative Job As President of Merck Vaccine Division

December 22, 2009

Natural News

By: Mike Adams

You’ve heard it before, how the pharmaceutical industry has a giant “revolving door” through which corporations and government agencies frequently exchange key employees. That reality was driven home in a huge way today when news broke that Dr. Julie Gerberding, who headed the CDC from 2002 through 2009, landed a top job with Merck, one of the largest drug companies in the world. Her job there? She’s the new president of the vaccine division.

How convenient. That means the former head of the CDC was very likely cultivating a relationship with Merck all these years, and now comes the big payoff: Heading up a $5 billion division that sells cervical cancer vaccines (like Gardasil), chickenpox vaccines and of course H1N1 swine flu vaccines, too.

So what’s the problem with all this? The problem is that private industry and government health offices such as the CDC or FDA should never be so cozy. When they are, it creates an environment of collusion between Big Government and Big Pharma. We’ve already seen this with the government-led push for swine flu vaccines that are manufactured (and sold) by drug companies like Merck.

You might even say that the CDC already functions as the marketing division of the pharmaceutical industry. It was the CDC that pushed so hard for swine flu vaccines, even amid the obvious realization that swine flu was no more dangerous than seasonal flu. To this day, the CDC still hasn’t bothered to recommend vitamin D for the prevention of either seasonal flu or swine flu. It remains heavily invested in the lucrative vaccine approach — an approach that just happens to financially benefit the very corporations that are hiring ex-CDC employees like Dr. Gerberding.

How to triple your salary by selling out to industry

Getting a job offer from Big Pharma, by the way, is one of the most-desired career paths for many CDC employees (and FDA workers, for that matter). It’s easy to accomplish it, too: Just operate in your government position as if you were a Big Pharma lackey. If you produce enough good business for the drug industry, sooner or later they’ll offer you a lucrative position that doubles or triples your government salary (or even better).

Now, I don’t want to lump all CDC employees in this same pathetic group, because there are indeed a great many bright, honest scientists working at the CDC who do excellent work tracking pandemics and trying to save lives. They are overshadowed, however, by those ambitious profit seekers who see their CDC job as merely a stepping stone for a far better-paying job at a major drug companies. And by any measure, Dr. Gerberding just cashed in big.

Her actual salary at Merck hasn’t been publicly released yet, but given that she’s heading up a $5 billion vaccine industry, it’s probably not chump change. I’d bet she’s now making at least ten times the salary of the President of the United States (and probably a lot more).

Click here for the full report

Is Big Pharma Covering Up Deaths?

October 5, 2009

LewRockwell.com

By Karen De Coster

A precious, innocent child’s life came to a cruel, sudden end. The Wall Street Journal reports that Natalie Morton, who died in England shortly following a Cervarix injection, did not die from the vaccination.The WSJ, in fact, almost appears to be swaggering behind its words. So you see, says the WSJ, no need to fear or stop the H1N1 vaccination program. There are pathology reports that absolve the vaccination and its maker. The HPV vaccinations are perfectly safe, as are the swine flu jabs. Thank goodness—I feel better already.

The pathology report states that she had an undiagnosed condition that was “so severe that death could have arisen at any point.” What was that condition? A “tumour in her chest involving her heart and her lungs.” A tumor (don’t like the Brit spelling) that just suddenly lashed out at her and attacked and killed, after producing no symptoms of a cancer tumor whatsoever? Is there a single person who is dumb enough to swallow this very inadequate version of her death?

I mentioned the other day that GlaxoSmithKline is working to get approval to sell Cervarix in the U.S. to compete against Merck’s Gardasil. Of course they wouldn’t allow a truthful report of this death, caused by the vaccination, to be revealed and thus deny its approval in the U.S., causing the loss of billions of dollars in revenue streams. As Mike Adams says, “This explanation is obviously a cover story to protect the vaccine industry; and it’s not even a convincing cover story at that.” Remember, this is a global vaccination program, with mandates growing and billions at stake. This is from the Wall Street Journal piece:

That sad case is a reminder to be wary of confusing proximity in time with cause and effect — a concept public-health officials have been citing in advance of the imminent roll out of the swine (H1N1) flu vaccine.

Ahh yes, coincidence! People, you see, may now fear the massive swine flu forced vaccination program the government is trying to shove down our throats. Can’t have that—declaring a worldwide pandemic and triggering hysteria means the growth of government control and a healthy, wealthy pharmaceutical industry.

Click here for the full report

Study Reveals Serious HPV Vaccine Problems: Fainting, Blood Clots, Death Among Risks

September 12, 2009

Natural News

By S.L. Baker

At first glance, a study just published in the August 19th edition of the Journal of the American Medical Association (JAMA) is yet another whitewash job about the safety of the quadrivalent human papillomavirus recombinant vaccine –better known as Gardasil, the genital human papillomavirus (HPV) vaccine. Licensed in June of 2006 by the Food and Drug Administration (FDA) for girls and young women between the ages of nine and 26, the enormously hyped and advertised vaccine is designed to prevent infection with four types of HPV: types 16 and 18 can cause cervical cancer and types 6 and 11 are the most common types of genital warts.

The JAMA report says that the Gardasil adverse events reported have been mostly consistent with data gathered before the vaccine was considered safe enough to be widely administered to young girls. But a close reading shows some disturbing additional facts.

Just as NaturalNews has consistently reported, the vaccine has caused an extraordinary number of adverse side effects. And now comes word from the JAMA report that the HPV vaccine has unexpectedly caused episodes of fainting and life-threatening blood clots. In fact, in a statement to the media, these events were called “disproportional” — meaning these side effects are anything but rare. What’s more, among the 12,424 adverse reaction reports about the HPV vaccine, 772 (6.2 percent) were serious and included 32 reports of death.

Other problems caused by the vaccine include local site reactions, skin rashes, nausea, dizziness, headaches and even Guillain-Barre syndrome (a disorder in which the body’s immune system attacks part of the peripheral nervous system sometimes causing paralysis) and anaphylaxis (hypersensitivity reaction that can cause sudden death). As just reported by CBS news, the teenage daughter of physician Scott Ratner and his wife was one of the unfortunate girls who became severely ill with a chronic autoimmune disease, myofasciitis, after her first dose of Gardasil. Dr. Ratner told CBS his daughter was so ill with the neurological problem “..she’d have been better off getting cervical cancer than the vaccination.”

One the lead researchers for Gardasil has also gone public this week, telling CBS news there is no data showing that the vaccine even remains effective beyond five years. That means that if a ten year old girl is given the vaccine and subjected to possibly serious and even life-threatening side effects, the vaccine may offer her no protection at all when she hits her teens or young adulthood.

What makes the debate about Gardasil crazy to begin with is that studies have shown 70 to 90 percent of people with HPV naturally clear the virus from the body within two years of infection — with no help from drugs or vaccines. So the most effective protection from problems caused by HPV is to avoid being infected by the multiple strains of HPV by not engaging in promiscuous, unprotected-by-condoms sex (the virus is transmitted sexually and condoms do not offer 100 percent protection) and by keeping your body’s immune system strong and healthy through good nutrition, exercise and exposure to sunlight.

In an editorial accompanying the JAMA study, Charlotte Haug, M.D., Ph.D., M.Sc., of The Journal of the Norwegian Medical Association in Oslo expressed her concerns about the aggressively promoted Gardasil vaccine: “Whether a risk is worth taking depends not only on the absolute risk, but on the relationship between the potential risk and the potential benefit. If the potential benefits are substantial, most individuals would be willing to accept the risks. But the net benefit of the HPV vaccine to a woman is uncertain. Even if persistently infected with HPV, a woman most likely will not develop cancer if she is regularly screened…”

Click here for the full report from Natural News

Is Merck Overselling a Cancer Vaccine?

August 27, 2009

Business Week

By Arlene Weintraub

Fresh controversies are heating up over the marketing of products to prevent cervical cancer

The U.S. Food & Drug Administration is gearing up to make critical decisions about two controversial vaccines. On Sept. 9 an FDA advisory committee will consider whether Merck (MRK)’s Gardasil, given to girls to prevent cancer-causing human papilloma virus (HPV), should be approved for use in boys, who can be HPV carriers. The same panel will also advise the agency on whether it should allow a new HPV vaccine, GlaxoSmithKline (GSK)’s Cervarix, to enter the U.S. market. The FDA doesn’t have to follow its panels’ recommendations, but it usually does.

Sales of Gardasil to prevent cervical cancer hit a respectable $1.4 billion last year, but they are already starting to slump, and fresh controversies could pour more cold water on this whole class of vaccines. Ever since Gardasil was approved in 2006, health-care watchdogs have griped that Merck has been overselling the vaccine’s cancer-beating power without having a full understanding of potential long-term risks. On Aug. 19, Columbia University professors Sheila M. and David J. Rothman published an article in the Journal of the American Medical Assn. blasting the company for paying grants to medical organizations that are strong advocates for vaccination. “Telling every mom she needs to get her daughters vaccinated to protect them from cancer is creating a market out of thin air,” David Rothman says. “They’re already protected” through regular pap smears, he adds.

Such criticisms mark a stark turnabout for a product once hailed as a breakthrough. Cervical cancer is a scourge: 11,000 cases are expected to be diagnosed this year, and 4,000 women will probably die of the disease, says the National Cancer Institute. The vaccine could prevent more than 70% of such cases. But from Day One, Merck has been lambasted for tactics such as lobbying lawmakers to make vaccination mandatory. After a strong start in the first two years, Gardasil sales fell 5% in 2008 and second-quarter sales are down 18% from a year earlier.

Dr. Richard M. Haupt, who heads the Gardasil research program for Merck, defends the company’s marketing. “Our goal is to act in the best interest of public health,” he says, noting that many organizations have spent money to promote the cause. Should boys be vaccinated? Merck has given the FDA data showing Gardasil prevents 90% of HPV symptoms in men, but since related male cancers are rare, the main justification is to protect their partners from cervical cancer. (Gathering data is also dicey because even if there were a drop-off in cases after widespread male vaccination, Merck could never prove its vaccine deserved more of the credit than, say, improved screening.)

Glaxo, for its part, doesn’t plan to market Cervarix to boys because it doesn’t think the strategy would be worth the expense. The Centers for Disease Control estimates that vaccinating males would cost the health-care system at least twice as much per year of added life as it costs to vaccinate females.

As for payments to medical organizations, Glaxo, Merck, and their beneficiaries say their disclosures are adequate. Two recipients, the American College of Obstetricians & Gynecologists and the Society of Gynecologic Oncologists, say they put the money to many uses beyond endorsing a specific vaccine. Meanwhile, Merck’s Haupt says the scandals are drawing attention away from what could be a public health boon. “I vaccinated both my daughters,” says the father of four. And if Gardasil is approved for boys, he says, “I plan to vaccinate both my sons.”

Click here for the full report from Business Week

CDC Report Stirs Controversy For Merck’s Gardasil Vaccine

August 19, 2009

ABC News

By Radha Chitale

A government report released Tuesday raises new questions about the safety of the cervical cancer vaccine Gardasil. The vaccine has been linked to 32 unconfirmed deaths and shows higher incidences of fainting and blood clots than other vaccines.

But while some physicians expressed concern over the findings, other doctors viewed the report as reassuring, showing that the vaccine was not associated with any more unusual and serious side effects as other vaccines.

The results of the report appeared along with an accompanying editorial discussing whether the potential benefit of the HPV vaccine is worth its potential risks in the Journal of the American Medical Association. The editorial, in particular, could give pause to many parents faced with the decision of whether or not to have their 11- and 12-year-old daughters vaccinated against the certain strains of the human papillomavirus, or HPV.

On Wednesday morning, ABC News Chief Medical Editor Dr. Timothy Johnson said that he, too, would encourage parents to learn more about the shot before getting their daughters vaccinated.

“I am very much in favor of childhood vaccines,” Johnson told Chris Cuomo on Wednesday’s “Good Morning America,” adding that there is little doubt that the vaccine does have its benefits.

“We know it does what it says it prevents HPV infections,” he said.

But he added that when it comes to comparing the benefits of the HPV vaccine against its potential risks, he believes there simply is not enough evidence to recommend to all parents that they have their daughters vaccinated.

“I don’t think we yet know the long term benefits or risks,” Johnson said. “I’m taking a pass on this one and saying to parents, ‘Study the issue, read the editorial… talk to your doctor.’”

Those who search for more information on the vaccine may also find stories from other parents who say the vaccine had ill effects on their daughters. One of these parents, Emily Tarsell, started her daughter Christina on Gardasil — a vaccine that protects against four of the most common cancer-causing strains of the human papilloma virus (HPV) — after her first visit to a gynecologist and at the doctor’s recommendation.

Eighteen days after Christina received her final vaccine shot, she died.

“I know it was the Gardasil,” Tarsell said, although the official cause of death was undetermined. “They were really recommending it, saying that there weren’t any side effects, that it was safe. So I kind of went against my better instinct [and let her] get the shot.”

Deaths like Christina’s are one of several types of complications reported to the U.S. Vaccine Adverse Event Reporting System (VAERS) following Gardasil distribution in 2006. Some of these adverse events were serious, including blood clots and neurological disorders, and some were non-life threatening side effects from the vaccine, including fainting, nausea and fever.

Although experts agree that the accuracy of data from VAERS reports — which can be made by anyone and are not verified or controlled for quality — is questionable, they remain divided as to whether extreme adverse events, which are serious but rare, are cause enough to stop recommending and administering the Gardasil vaccine without further investigation.

Report Shows Rare But Serious Side Effects May Result From Gardasil Vaccine
“Although the number of serious adverse events is small and rare, they are real and cannot be overlooked or dismissed without disclosing the possibility to all other possible vaccine recipients,” said Dr. Diane Harper, director of the Gynecologic Cancer Prevention Research Group at University of Missouri. “The rate of serious adverse events is greater than the incidence rate of cervical cancer.”

As of June 1, 2009, the CDC reported that over 25 million doses of Gardasil, which is recommended for women between ages 9-26, have been distributed in the U.S. and there was an average of 53.9 VAERS reports per 100,000 vaccine doses. Of these, 40 percent occurred on the day of vaccination, and 6.2 percent were serious, including 32 reports of death.

In a statement yesterday from Merck, the pharmaceutical company that manufactures Gardasil, the company backed the vaccine’s efficacy and said they encourage further research on its safety.

“We are pleased that the study published by JAMA [yesterday] further reinforces the safety profile of Gardasil,” said Dr. Richard M. Haupt, head of the clinical program for Gardasil at Merck. “We welcome continued study and discussion about the safety of this important vaccine.”

But some clinicians are not ready to accept wide use of the drug based on the available safety data.

Dr. Jaques Moritz, director of gynecology at St. Luke’s-Roosevelt Hospital, said he would not offer the Gardasil vaccine to patients when good cervical cancer screening techniques and treatments exist. He has also chosen not to have his 11-year-old daughter get the HPV shot because of his concerns.

“I’m pro preventing cervical cancer and HPV,” Moritz said. “I’m not pro that the physicians don’t know the risks and side effects.”

Click here to continue reading the full report from ABC News